Track the SCL사이언스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, SCL사이언스 has recorded 56 public disclosures. Market capitalisation: €66.3bn. The latest transaction was reported on 27 May 2026 (Purchase). Among the most active insiders: 대신신기술투자조합제15호. The full history is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
34 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 26,862 of 28,822 companies
18.1
score / 100
Value
20
Quality
17
FCF yld-6.8%
Earn yld-5.8%
EV/EBITDA·
ROE-13%
Gross mgn19%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
SCL사이언스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.